AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Relapsed Small Cell Lung Cancer

Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer NCT07189455Phase 31 site๐Ÿ“ Shanghai Suzhou Zelgen Biopharmaceuticals Co.,Ltd ยท Tests: ZG006, Topotecan A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer NCT06954246Phase 31 site๐Ÿ“ Shanghai Qilu Pharmaceutical Co., Ltd. ยท Tests: MHB088C for Injection, Topotecan, Irinotecan, Paclitaxel A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma NCT03460977Phase 185 sites๐Ÿ“ Tucson๐Ÿ“ Tucson๐Ÿ“ Tucson Pfizer ยท Tests: Mevrometostat (PF-06821497), Enzalutamide, Itraconazole A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) NCT05865002Phase 137 sites๐Ÿ“ Vijayawada๐Ÿ“ Visakhapatnam๐Ÿ“ Chandigarh Aurigene Discovery Technologies Limited ยท Tests: AUR107 Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors NCT04777994Phase 130 sites๐Ÿ“ Tucson๐Ÿ“ New Haven๐Ÿ“ Baltimore Calico Life Sciences LLC ยท Tests: ABBV-CLS-484, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI), Programmed Cell Deatโ€ฆ Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer NCT06931626Phase 13 sites๐Ÿ“ Peoria๐Ÿ“ Boston๐Ÿ“ Nashville Nerviano Medical Sciences ยท Tests: NMS-03305293, Temozolomide A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301] NCT07099898Phase 3144 sites๐Ÿ“ Los Angeles๐Ÿ“ Miami๐Ÿ“ Plantation GlaxoSmithKline ยท Tests: Risvutatug rezetecan (Ris-Rez), Topotecan A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer NCT07603856Phase 21 site๐Ÿ“ Chicago University of Chicago ยท Tests: Investigator Choice Immunotherapy (for example: pembrolizumab, cemiplimab, durvalumab, ipilimumab plus nivolumab), Inveโ€ฆ Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC). NCT06663098Phase 225 sites๐Ÿ“ Aviano (PN)๐Ÿ“ Bari๐Ÿ“ Bologna Gruppo Oncologico Italiano di Ricerca Clinica ยท Tests: Atezolizumab, Carboplatin, Etoposide Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC NCT05669846Phase 21 site๐Ÿ“ Pittsburgh Diwakar Davar ยท Tests: Healthy Donor Fecal Microbiota Transplant (hdFMT), Pembrolizumab Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial NCT06262386NA1 site๐Ÿ“ Taoyuan City Chang Gung Memorial Hospital ยท Tests: Cisplatin based chemottherapy Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC NCT06681220Phase 1, Phase 211 sites๐Ÿ“ Palo Alto๐Ÿ“ Chicago๐Ÿ“ Indianapolis VA Office of Research and Development ยท Tests: Stenoparib/Temozolomide, Lurbinectedin, Stenoparib/Temozolomide A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1) NCT07488923Phase 17 sites๐Ÿ“ St Louis๐Ÿ“ Hackensack๐Ÿ“ New York Moonlight Bio, Inc ยท Tests: ML261 A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer NCT07325136Phase 1, Phase 213 sites๐Ÿ“ Detroit๐Ÿ“ Buffalo๐Ÿ“ Durham Bristol-Myers Squibb ยท Tests: BMS-986525, Pumitamig Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC) NCT07778316Phase 39 sites๐Ÿ“ Orlando๐Ÿ“ Grand Rapids๐Ÿ“ Omaha Amgen ยท Tests: Tarlatamab A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors NCT06956690Phase 1, Phase 27 sites๐Ÿ“ La Jolla๐Ÿ“ Indianapolis๐Ÿ“ Farmington Hills Hummingbird Bioscience ยท Tests: ENV-501 TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors NCT07713732Phase 13 sites๐Ÿ“ Camperdown๐Ÿ“ Malvern๐Ÿ“ Nedlands Treeline Biosciences, Inc. ยท Tests: TLN-499, Venetoclax Evaluation of XYA02 in Patients With Advanced Solid Tumors NCT07670312Phase 1, Phase 25 sites๐Ÿ“ Sydney๐Ÿ“ Sydney๐Ÿ“ Melbourne XYone Therapeutics, Inc ยท Tests: XYA02 Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer NCT04919382Phase 25 sites๐Ÿ“ Chicago๐Ÿ“ Indianapolis๐Ÿ“ Iowa City Dwight Owen ยท Tests: Atezolizumab, Temozolomide Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer NCT05450965Phase 22 sites๐Ÿ“ Baltimore๐Ÿ“ Pittsburgh University of Maryland, Baltimore ยท Tests: Onvansertib Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer NCT06467786Phase 41 site๐Ÿ“ Xi'an Tang-Du Hospital ยท Tests: Irinotecan hydrochloride liposome injection A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer NCT06203210Phase 3229 sites๐Ÿ“ Springdale๐Ÿ“ Fullerton๐Ÿ“ Los Angeles Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan, Topotecan, Amrubicin, Lurbinectedin Phase I Clinical Study of ฮฑ-PD-L1/DLL3 CAR-T in Patients With R/R SCLC NCT06348797Phase 11 site๐Ÿ“ Chengdu Sichuan University ยท Tests: ฮฑ-PD-L1/4-1BB DLL3 CAR-T (BHP01) A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma NCT05456256Phase 216 sites๐Ÿ“ Beverly Hills๐Ÿ“ Fountain Valley๐Ÿ“ Los Alamitos Lantern Pharma Inc. ยท Tests: LP-300, Pemetrexed, Carboplatin Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer NCT06463665Phase 215 sites๐Ÿ“ Bullhead City๐Ÿ“ Clermont๐Ÿ“ Coral Springs Genelux Corporation ยท Tests: Olvimulogene nanivacirepvec, Platinum chemotherapy: carboplatin or cisplatin, Non-platinum chemotherapy: paclitaxel or โ€ฆ This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer. NCT07249879Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: GC511B CAR-T Cell Injection TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC NCT07246304EARLY Phase 11 site๐Ÿ“ Nanjing TCRCure Biopharma Ltd. ยท Tests: TC-D101 CAR-T APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors NCT03175224Phase 235 sites๐Ÿ“ Los Angeles๐Ÿ“ Tampa๐Ÿ“ Boston Apollomics Inc. ยท Tests: APL-101 Oral Capsules A Phase IIII Study of AL8326 in Small Cell Lung Cancer NCT06247605Phase 31 site๐Ÿ“ Changchun Advenchen Laboratories Nanjing Ltd. ยท Tests: AL8326 tablets, placebo Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer NCT06128837Phase 31 site๐Ÿ“ Beijing Luye Pharma Group Ltd. ยท Tests: Irinotecan hydrochloride liposome Injection, Topotecan
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy